Haleos Labs (BOM:540679) OCF Margin %: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:540679 Haleos Labs Ltd BOM:540679
72 GF Score
Price ₹1,600.00
GF Value ₹1,129.58
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is Haleos Labs OCF Margin %?

Haleos Labs BOM:540679 -2.74% 72 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates BOM:540679 with a GF Score™ of 72/100 and a GF Value™ of ₹1,129.58 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 950 Biotechnology companies, Haleos Labs ranks better than 77.16% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Haleos Labs's Cash Flow from Operations for the three months ended in Mar. 2026 was ₹0 Mil. Haleos Labs's Revenue for the three months ended in Mar. 2026 was ₹751 Mil. Therefore, Haleos Labs's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Haleos Labs's current OCF Yield % is 7.70%.

The historical rank and industry rank for Haleos Labs's OCF Margin % or its related term are showing as below:

BOM:540679' s OCF Margin % Range Over the Past 10 Years
Min: -3.24   Med: 8.08   Max: 13.66
Current: 11.15

During the past 11 years, the highest OCF Margin % of Haleos Labs was 13.66%. The lowest was -3.24%. And the median was 8.08%.

BOM:540679's OCF Margin % is ranked better than
77.16% of 950 companies
in the Biotechnology industry
Industry Median: -64.565 vs BOM:540679: 11.15

Haleos Labs OCF Margin % Related Terms

Haleos Labs OCF Margin % Historical Data

* Premium members only.

The historical data trend for Haleos Labs's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Haleos Labs OCF Margin % Chart

Haleos Labs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.24 4.70 8.11 9.88 11.15

Haleos Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BOM:540679 vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Haleos Labs's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Haleos Labs OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Haleos Labs's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Haleos Labs's OCF Margin % falls into.


BOM:540679
72GF Score
Haleos Labs Ltd BOM:540679
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Haleos Labs OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Haleos Labs's OCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=372.235/3337.945
=11.15 %

Haleos Labs's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=0/751.391
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Haleos Labs (BOM:540679) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Haleos Labs and its competitors. According to the industry distribution chart, Haleos Labs ranks #217 out of 950 companies in the Biotechnology industry, placing it in the top 22.8%.
Is Haleos Labs' OCF Margin % too high?
Haleos Labs' current OCF Margin % is 0.00%. Based on the distribution chart, Haleos Labs ranks #217 out of 950 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Haleos Labs has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Haleos Labs' OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Haleos Labs ranks #217 out of 950 companies for OCF Margin %. This places Haleos Labs in the top 23% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Haleos Labs and its competitors. Haleos Labs's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haleos Labs stock overvalued right now?
Based on GuruFocus' analysis, Haleos Labs (BOM:540679) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1,129.58, compared to a current price of ₹1,600.00 — trading 41.6% above its estimated fair value. The current OCF Margin % is 0.00%. Haleos Labs' overall GF Score™ is 72/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Haleos Labs (BOM:540679), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Haleos Labs (BOM:540679) Overvalued in 2026?

Based on GuruFocus' analysis, Haleos Labs stock appears to be overvalued. The current stock price of ₹1,600.00 is trading 41.6% above its estimated GF Value™ of ₹1,129.58. GuruFocus considers Haleos Labs to be Significantly Overvalued.

Key valuation signals for BOM:540679:

  • OCF Margin %: 0.00%
  • GF Value™: ₹1,129.58 vs. price of ₹1,600.00 (41.6% above fair value)
  • GF Score™: 72/100 with 10 warning signs

No single metric tells the full story. See the BOM:540679 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Haleos Labs Business Description

Other Exchanges HALEOSLABS:India
Address Road Number 71, Plot Number 19 - III, Opposite Bharatiya Vidya Bhavan Public School, Jubilee Hills, Hyderabad, TG, IND, 500096
Haleos Labs Ltd is engaged in the Business of manufacturing Active Pharmaceutical Ingredients (APIs) and its intermediates and sells its products in India as well as exports. The group sells its products in India and also exports it to other countries. Some of its API products are used in therapy as an Antiulcer, Antifungal, Anti Obesity, Anesthesia, and others. The company has manufacturing facilities at Kazipally and Jeedimetla and its Research and Development center at Sanatnagar in Hyderabad.
72GF Score

Get the complete analysis for BOM:540679

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,600.00
Price
₹1,129.58
GF Value